Starget Pharma Inc. funding
Starget Pharma Inc., a biotechnology company based in Shreveport, LA (founded 2025), filed a Form D with the SEC on February 3, 2026 and reported $16.4M raised of a $22.2M offering.
Amount raised$16.4M
Offering size$22.2M
Filed with the SECFebruary 3, 2026
First saleJanuary 20, 2026
IndustryBiotechnology
SecuritiesEquity
LocationShreveport, LA
Founded2025
Entity typeCorporation
Investors so far29
Minimum investment$50K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 3